scholarly article | Q13442814 |
P50 | author | Mark E Hatley | Q58360989 |
P2093 | author name string | Eric N Olson | |
Ning Liu | |||
David Finkelstein | |||
Wei Tang | |||
Rene L Galindo | |||
Matthew R Garcia | |||
Jonathan Graff | |||
Douglas P Millay | |||
P2860 | cites work | Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice | Q24557452 |
Identification and importance of brown adipose tissue in adult humans | Q24632425 | ||
Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex | Q24643490 | ||
PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells | Q24651250 | ||
PRDM16 controls a brown fat/skeletal muscle switch | Q24657178 | ||
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus | Q24797230 | ||
Generalized lacZ expression with the ROSA26 Cre reporter strain | Q27860837 | ||
A mouse model for medulloblastoma and basal cell nevus syndrome | Q28206586 | ||
The Hedgehog response network: sensors, switches, and routers | Q28267648 | ||
Human homolog of patched, a candidate gene for the basal cell nevus syndrome | Q28281033 | ||
Cold-activated brown adipose tissue in healthy men | Q29547382 | ||
The landscape of somatic copy-number alteration across human cancers | Q29547648 | ||
Functional brown adipose tissue in healthy adults | Q29547687 | ||
A new look at the origin, function, and "stem-cell" status of muscle satellite cells | Q33828880 | ||
A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo | Q33923356 | ||
Cross-species genomics matches driver mutations and cell compartments to model ependymoma | Q34031780 | ||
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma | Q34405491 | ||
Beta-catenin activation is necessary and sufficient to specify the dorsal dermal fate in the mouse | Q34531372 | ||
Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma | Q34580128 | ||
Targeted expression of Cre recombinase to adipose tissue of transgenic mice directs adipose-specific excision of loxP-flanked gene segments | Q34630211 | ||
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma | Q34642090 | ||
Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle | Q34790967 | ||
Expression of cardiac ankyrin repeat protein, CARP, in malignant tumors: diagnostic use of CARP protein immunostaining in rhabdomyosarcoma | Q34801110 | ||
A Drosophila model of the rhabdomyosarcoma initiator PAX7-FKHR. | Q35037288 | ||
Stem cells for skeletal muscle repair | Q35088530 | ||
Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group. | Q35188293 | ||
Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells | Q35647795 | ||
The fetal form of the acetylcholine receptor distinguishes rhabdomyosarcomas from other childhood tumors | Q35763741 | ||
Pax genes in embryogenesis and oncogenesis | Q35886629 | ||
A set of imprinted genes required for normal body growth also promotes growth of rhabdomyosarcoma cells | Q36169619 | ||
New genetic tactics to model alveolar rhabdomyosarcoma in the mouse | Q36248565 | ||
Hibernoma formation in transgenic mice and isolation of a brown adipocyte cell line expressing the uncoupling protein gene | Q37154626 | ||
A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway | Q37249645 | ||
Signatures of mutation and selection in the cancer genome | Q39737975 | ||
Mutation and expression analyses of the MET and CDKN2A genes in rhabdomyosarcoma with emphasis on MET overexpression | Q40180061 | ||
Preservation of the bladder in patients with rhabdomyosarcoma | Q40915969 | ||
White fat progenitor cells reside in the adipose vasculature. | Q41145314 | ||
Patterning of mammalian somites by surface ectoderm and notochord: evidence for sclerotome induction by a hedgehog homolog | Q41407222 | ||
Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements | Q42131094 | ||
Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development | Q42486654 | ||
Hedgehog signaling plays a conserved role in inhibiting fat formation | Q42806335 | ||
Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma | Q42811960 | ||
Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome | Q44178518 | ||
A multifunctional reporter mouse line for Cre- and FLP-dependent lineage analysis. | Q50605367 | ||
Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development. | Q50722545 | ||
HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy. | Q52030611 | ||
Early myotome specification regulates PDGFA expression and axial skeleton development. | Q52163433 | ||
Combinatorial signaling by Sonic hedgehog and Wnt family members induces myogenic bHLH gene expression in the somite. | Q52204666 | ||
Ectopic expression of Sonic hedgehog alters dorsal-ventral patterning of somites. | Q52212312 | ||
Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. | Q52547784 | ||
Loss of suppressor-of-fused function promotes tumorigenesis. | Q53334228 | ||
Molecular signature of quiescent satellite cells in adult skeletal muscle. | Q53543981 | ||
Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. | Q54434638 | ||
High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis. | Q54603571 | ||
Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. | Q55475439 | ||
Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma | Q57243407 | ||
Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors | Q68494061 | ||
Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma | Q73490609 | ||
Polysialylated neural cell adhesion molecule in childhood rhabdomyosarcoma | Q74053365 | ||
A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance | Q77652485 | ||
Insertion of Cre into the Pax3 locus creates a new allele of Splotch and identifies unexpected Pax3 derivatives | Q81729304 | ||
Muscling in: Uncovering the origins of rhabdomyosarcoma | Q82793750 | ||
P433 | issue | 4 | |
P921 | main subject | adipocyte | Q357519 |
rhabdomyosarcoma | Q1898141 | ||
P304 | page(s) | 536-546 | |
P577 | publication date | 2012-10-01 | |
P1433 | published in | Cancer Cell | Q280018 |
P1476 | title | A mouse model of rhabdomyosarcoma originating from the adipocyte lineage | |
P478 | volume | 22 |
Q91710887 | A Case of mistaken identity: Rhabdomyosarcoma development from endothelial progenitor cells |
Q36367000 | A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies |
Q46456978 | A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo |
Q91906063 | Animal models of well-differentiated/dedifferentiated liposarcoma: utility and limitations |
Q38842344 | Autoregulatory loop between TGF-β1/miR-411-5p/SPRY4 and MAPK pathway in rhabdomyosarcoma modulates proliferation and differentiation |
Q47793645 | Biallelic Dicer1 Loss Mediated by aP2-Cre Drives Angiosarcoma. |
Q89722579 | CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG |
Q38215035 | Canonical and non-canonical Hedgehog signalling and the control of metabolism |
Q38893243 | Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma |
Q35549055 | Cell-autonomous activation of Hedgehog signaling inhibits brown adipose tissue development |
Q38634438 | Current management of paratesticular rhabdomyosarcoma |
Q38367725 | Decoding the 'embryonic' nature of embryonal rhabdomyosarcoma |
Q34663937 | Delta-like 1 homolog (dlk1): a marker for rhabdomyosarcomas implicated in skeletal muscle regeneration. |
Q41917751 | Distinct cellular origin and genetic requirement of Hedgehog-Gli in postnatal rhabdomyosarcoma genesis |
Q38297328 | Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma. |
Q47121024 | Embryonal rhabdomyosarcoma in the maxillary sinus with orbital involvement in a pediatric patient: Case report |
Q38103175 | Function of oncogenes in cancer development: a changing paradigm |
Q33899910 | Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma |
Q50116993 | Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors. |
Q43080027 | Hedgehog-driven myogenic tumors recapitulate skeletal muscle cellular heterogeneity |
Q38834036 | Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells |
Q36739725 | Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes |
Q35861006 | Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma |
Q37672882 | Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization. |
Q89419514 | Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes |
Q35987311 | Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation |
Q30411722 | Lineage of origin in rhabdomyosarcoma informs pharmacological response |
Q34550706 | Loss of Pin1 Suppresses Hedgehog-Driven Medulloblastoma Tumorigenesis |
Q26852728 | Mechanisms of impaired differentiation in rhabdomyosarcoma |
Q34654560 | Mesenchymal stem cell transformation and sarcoma genesis |
Q33688560 | MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis |
Q39069676 | Molecular diagnostics in the management of rhabdomyosarcoma |
Q26783611 | Non-Canonical Hh Signaling in Cancer-Current Understanding and Future Directions |
Q28389770 | Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice |
Q38740103 | P/CAF mediates PAX3-FOXO1-dependent oncogenesis in alveolar rhabdomyosarcoma. |
Q47713399 | PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma |
Q37482775 | PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma. |
Q27023560 | Pediatric solid tumor genomics and developmental pliancy |
Q26798810 | Potential of adipose-derived stem cells in muscular regenerative therapies |
Q28512043 | Primary cilia control hedgehog signaling during muscle differentiation and are deregulated in rhabdomyosarcoma |
Q36142754 | Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems. |
Q34255856 | Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma |
Q30855713 | Regulatory landscape fusion in rhabdomyosarcoma through interactions between the PAX3 promoter and FOXO1 regulatory elements |
Q95388147 | Rhabdomyosarcoma |
Q26784207 | Rhabdomyosarcoma: Advances in Molecular and Cellular Biology |
Q34400242 | Rhabdomyosarcoma: current challenges and their implications for developing therapies. |
Q37162388 | Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma |
Q39153280 | TGF-β1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma |
Q37232227 | Targeting hedgehog signaling in cancer: research and clinical developments |
Q38864787 | The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities |
Q36240079 | The Hedgehog pathway: role in cell differentiation, polarity and proliferation |
Q41575226 | The not-so-skinny on muscle cancer |
Q41778571 | Tumor Induction in Mice After Localized Single- or Fractionated-Dose Irradiation: Differences in Tumor Histotype and Genetic Susceptibility Based on Dose Scheduling |
Q90364706 | Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas |
Q38553827 | Uncovering metabolism in rhabdomyosarcoma. |
Q33895506 | What is new in the biology and treatment of pediatric rhabdomyosarcoma? |
Q38831343 | Zebrafish Rhabdomyosarcoma |
Q36975776 | Zebrafish rhabdomyosarcoma reflects the developmental stage of oncogene expression during myogenesis |
Q37428692 | miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma. |
Search more.